compounded semaglutide vs non compounded semaglutide & Tirzepatide 2025: Safe Use Guide Branded vs. Compounded GLP-1s: What’s
Description
Wegovy is approved for chronic weight management and cardiovascular risk reduction in adults with obesity or overweight

For example, Kaiser Permanente Northwest Region covers Wegovy as a prescription drug benefit if patients meet the following criteria: Have been diagnosed with chronic weight management Are 18 years or older Have documented their current weight and body mass index (BMI) Are actively following a diet and exercise program Have a BMI of 30 or higher or have a BMI of 27 or higher, plus hypertension, diabetes, or hyperlipidemia Failed a three-month trial or has an allergy, intolerance, or contraindication to phentermine, diethylpropion, Qsymia, and Contrave Failed a three-month trial of Ozempic Medicare doesnt cover medications strictly for weight loss, so Kaiser Medicare Part D plans typically wont cover Wegovy for weight loss alone

Your physician can assess whether the benefits of continuing the weight loss injection outweigh the gastrointestinal burden

You might see 1 to 2 pounds per week at this stage, though weight loss is rarely linear

Probably not, but it's going to be a fast follow," Carroll said
